Literature DB >> 20828942

Mortality among cocaine users: a systematic review of cohort studies.

Louisa Degenhardt1, Jessica Singleton, Bianca Calabria, Jennifer McLaren, Thomas Kerr, Shruti Mehta, Gregory Kirk, Wayne D Hall.   

Abstract

AIMS: To conduct a systematic review of mortality among cohort studies of cocaine users.
METHODS: Three electronic databases were searched (EMBASE, Medline and PsychINFO); other online databases were searched using online libraries and repositories of reports and literature in the drug and alcohol field, with requested contributions from trained librarians and experts. Searches and extraction were undertaken using protocols and cross-checking of decisions by two authors. Additional data were requested from study investigators where studies did not report relevant data.
RESULTS: 1911 articles and 2 reports were identified from searches, with data from another four studies located from review articles. Seven cohorts of "problem" or dependent cocaine users reported data that permitted mortality rates to be estimated. Crude mortality rates ranged from 0.53 (95% CI: 0.10-1.58) to 6.16 (95% CI: 5.21-7.11) per 100 PY. Standardised mortality ratios (SMRs) reported in four studies suggested that mortality was four to eight times higher among cocaine users than age and sex peers in the general population.
CONCLUSIONS: There are limited data on the extent of elevated mortality among problematic or dependent cocaine users and it is unclear how generalisable the results of these studies may be to other populations of problematic cocaine users. Greater attention to both the method of recruitment, and the characteristics of cocaine users, would enhance our understanding of the mortality risks of problematic cocaine use.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20828942     DOI: 10.1016/j.drugalcdep.2010.07.026

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  52 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Mortality among substance-using mothers in California: a 10-year prospective study.

Authors:  Yih-Ing Hser; Jamie Kagihara; David Huang; Elizabeth Evans; Nena Messina
Journal:  Addiction       Date:  2011-10-26       Impact factor: 6.526

3.  Prospective effects of traumatic event re-exposure and post-traumatic stress disorder in syringe exchange participants.

Authors:  Jessica M Peirce; Robert K Brooner; Ken Kolodner; Rebecca L Schacht; Michael S Kidorf
Journal:  Addiction       Date:  2012-10-05       Impact factor: 6.526

4.  Correlates of polysomnographic sleep changes in cocaine dependence: self-administration and clinical outcomes.

Authors:  Gustavo A Angarita; Sofija V Canavan; Erica Forselius; Andrew Bessette; Peter T Morgan
Journal:  Drug Alcohol Depend       Date:  2014-07-30       Impact factor: 4.492

5.  A Hazard Analysis of Risk Factors of Mortality in Individuals Who Inject Drugs in Denver CO.

Authors:  Jonathan M Davis; Katie Suleta; Karen F Corsi; Robert E Booth
Journal:  AIDS Behav       Date:  2017-04

6.  Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths.

Authors:  Joshua A Barocas; Jianing Wang; Brandon D L Marshall; Marc R LaRochelle; Amy Bettano; Dana Bernson; Curt G Beckwith; Benjamin P Linas; Alexander Y Walley
Journal:  Drug Alcohol Depend       Date:  2019-05-08       Impact factor: 4.492

7.  Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.

Authors:  Theresa Winhusen; Jeff Theobald; David C Kaelber; Daniel Lewis
Journal:  Addiction       Date:  2019-04-25       Impact factor: 6.526

8.  Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Robert Lindblad; Lian Hu; Neal Oden; Paul Wakim; Carmen Rosa; Paul VanVeldhuisen
Journal:  J Subst Abuse Treat       Date:  2016-08-15

9.  Association Between Quality Measures and Mortality in Individuals With Co-Occurring Mental Health and Substance Use Disorders.

Authors:  Katherine E Watkins; Susan M Paddock; Teresa J Hudson; Songthip Ounpraseuth; Amy M Schrader; Kimberly A Hepner; Greer Sullivan
Journal:  J Subst Abuse Treat       Date:  2016-06-07

10.  Baseline medical comorbidities in adults randomized in the STRIDE trial for psychostimulant use disorders.

Authors:  Adriane M Dela Cruz; Thomas Carmody; Tracy L Greer; Chad D Rethorst; Diane Warden; Robrina Walker; Madhukar H Trivedi
Journal:  Am J Addict       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.